FDA Approves Noven Pharmaceuticals’ Transdermal Patch for SchizophreniaApprovals, Atypical Antipsychotics, Blood Pressure, Boxed Warning, Clinical Data, FDA, FDA/Regulatory, Schizophrenia, Shares, Transdermal PatchesNoven Pharmaceuticals won approval from the U.S. Food and Drug Administration for the company’s transdermal schizophrenia patch. Read more October 15, 2019/by BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2019-10-15 12:53:582019-10-15 13:10:29FDA Approves Noven Pharmaceuticals’ Transdermal Patch for Schizophrenia